Resultados de la búsqueda 641-650 of 19347 for WHO
... who remain unimpaired at older ages due to unknown protective factors and spared pathophysiological effects despite their genetic risk. A Study to Evaluate ...
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
... who have Bacillus-Calmette-Guerin (BCG) unresponsive disease, with either ... who have failed 1-2 prior lines of therapy. The primary objectives are to ...
This study will include some patients receiving the hormone therapy and some patients who are not, so we can better understand whether patients getting the ...
Centralized follow-up will be conducted by having sites upload patient data following each visit via the web-based data system, with patients who do not ...
The purpose of this study is to develop a Registry of participants with MacTel Type 2 (as confirmed by the Reading Center) who may agree to be contacted for ...
... who have previously received 177Lu-DOTATATE for midgut neuroendocrine tumor ... who progressed on a prior ARPI treatment with normal renal function or ...
The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...
Mayo Clinic's skull base tumors specialty group Skull Base Tumors Specialty Group in the Brain Tumor Program offers experts who are pioneering new treatment and ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?